DPP4 and Obesity: There were significant differences in the frequency of receiving metformins, TZDs, DPP4 inhibitors, ARBs, CCBs, Beta blockers, statins, UA lowering agents and anti-platelet agents among the four categories of body composition, when using BMI for the classification of obesity (Additional file 1: Table S6).